The development of scientific solutions for functional foods, sports or infantile nutrition to enter the nutraceuticals and cosmeceuticals’ markets becomes more and more strategic for the food / feed, cosmetic and pharmaceutical industries, especially since nutritional and health claims are now acting at the governments’ level. [+] for futher information, go to the web site of (...)
67 biotech companies
In the spring of 2014, the IMT (Institut des Métiers et des Technologies) opened a working conditions-based training facility at Genopole to prepare people for careers in biotech and drug bioproduction. The IMT has provided training for operational and technical careers in pharmaceutical production for more than 30 years. Its offer includes professional degrees and continuing education. Every year, IMT accepts an average of 750 students or job seekers for training and/or accompaniment (...)
Genopole, France’s leading biopark for life sciences research, and Amgen, a pioneer in medical biotech, have joined forces to co-organize the International Colloquium on Innovation. The objective of the event is to better understand 1- the organization of innovation systems throughout the world 2- the specificities of major innovation sectors and channels including 3- those of biomedical innovation 4- the role of regions in innovation with the goal of identifying best practices through (...)
The Genopole Enterprises team is made up of experienced project managers with complementary skills and backgrounds, covering the full range of "hands-on" activities in business start-up and development. From the birth of the idea in the lab through to market validation, Genopole delivers scientific, managerial, material and financial assistance to budding and confirmed entrepreneurs, in close collaboration with other start-up support organizations and the venture capital and financial (...)
Its development strategy seeks to : 1/ place Genopole among the 10 leading high-tech life sciences bioclusters worldwide 2/ advance personalized, regenerative medicine (“genobiomedicine”) in collaboration with the South Ile-de-France Medical Center (CHSF) 3/ organize and develop stem cell, bioproduction and synthetic biology mini-clusters 4/ favor the development of environmental, agronomic and industrial biotechnologies 5/ enable the continued growth of its park of biotech companies by (...)
Marianne Duraton named president of Genopole.